S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments
CURE sat down with Dr. Natalie S. Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with metastatic triple-negative breast cancer. Berg...
31 Joulu 202514min
S7 Ep1: The Importance of Spotting Endometrial Cancer
Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
18 Maalis 202510min
S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care
17 Syys 202419min
S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma. And finally, we’ll discuss another ca...
4 Maalis 20247min
S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, an...
4 Maalis 202410min
S6 Ep20: FDA Approvals from February 2024
Last week, the Food and Drug Administration (FDA) approved four different therapies in the oncology space — one of which, Amtagvi, marks the first cellular therapy for the treatment of solid cancers. ...
23 Helmi 20246min
S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development
Last week, we saw some FDA approvals for a new drug regimens, as well as some expert opinion about cancer vaccines. Additionally research touched upon the potential benefit of concurrent ctDNA and tum...
19 Helmi 20249min
S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews. Also last week, we covered researc...
12 Helmi 20247min
